Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001140361-21-021557
Filing Date
2021-06-21
Accepted
2021-06-21 06:41:11
Documents
15

Document Format Files

Seq Description Document Type Size
1 F-1/A nt10022430x4_f1a.htm F-1/A 2884784
2 EXHIBIT 1.1 nt10022430x4_ex1-1.htm EX-1.1 306432
3 EXHIBIT 3.1 nt10022430x4_ex3-1.htm EX-3.1 275349
4 EXHIBIT 3.2 nt10022430x4_ex3-2.htm EX-3.2 594623
5 EXHIBIT 5.1 nt10022430x4_ex5-1.htm EX-5.1 52603
6 EXHIBIT 10.1 nt10022430x4_ex10-1.htm EX-10.1 238668
7 EXHIBIT 10.2 nt10022430x4_ex10-2.htm EX-10.2 130083
8 EXHIBIT 23.1 nt10022430x4_ex23-1.htm EX-23.1 2212
9 logo_ghhealth.jpg GRAPHIC 41620
10 nt10022430x4_barchart1.jpg GRAPHIC 196639
11 nt10022430x4_barchart1a.jpg GRAPHIC 239516
12 nt10022430x4_diagram2.jpg GRAPHIC 211843
13 nt10022430x4_diagram3.jpg GRAPHIC 163961
14 nt10022430x4_ex5-1img01.jpg GRAPHIC 7294
15 nt10022430x4_molecules.jpg GRAPHIC 49396
  Complete submission text file 0001140361-21-021557.txt   5738426
Mailing Address 28 BAGGOT STREET LOWER DUBLIN L2 2D02 NX43
Business Address 28 BAGGOT STREET LOWER DUBLIN L2 2D02 NX43 353 1 437 8443
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-256796 | Film No.: 211027295
SIC: 2834 Pharmaceutical Preparations